Should antithrombotic therapy be different in patients with atrial fibrillation and a so-called temporary cause and especially after an acute coronary syndrome?
ConclusionIn patients with a possibly TCAF, use of oral anticoagulation was independently associated with a better prognosis. Antiplatelet therapy use was also independently associated with a better prognosis when patients with TCAF had ACS.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
More News: Alcoholism | Atrial Fibrillation | Cardiology | Cardiovascular | Databases & Libraries | Heart | Hyperthyroidism | Myocarditis | Stroke | Thrombosis